by Emily C | May 12, 2020 | Canadian Regulatory, OTC Drugs, Research/Science/Technology, U.S. Regulatory, Uncategorized
Recently, Health Canada announced that the Regulatory Enrolment Process (REP) will be mandatory to use as of October 1, 2020. The Health Products and Food Branch (HPFB) will be implementing this single window for transmission of regulatory transactions in electronic...
by Emily C | Apr 3, 2020 | Canadian Regulatory, Innovation, Medical Devices, Research/Science/Technology, U.S. Regulatory
Recently, information has been provided regarding updates that Health Canada and the U.S. FDA have done in order to aid in the battle against COVID-19. However, other countries have also taken drastic measures to assist with reducing the spread of COVID-19. The...
by Emily C | Apr 3, 2020 | Canadian Regulatory, Medical Devices, Natural Health Products, Research/Science/Technology
Earlier this year, information about new regulations and requirements put in place by Health Canada for product’s containing nitrosamine impurities was released. These regulations are applicable to prescription and non-prescription pharmaceuticals containing...
by Emily C | Mar 27, 2020 | Canadian Regulatory, Cosmetics, Natural Health Products, Research/Science/Technology, U.S. Regulatory
The U.S. FDA has released new regulations for essential products that will aid in limiting the spread of coronavirus, such as sanitizers. These new regulations have been placed into effect immediately and are being modified and reintroduced in order to minimize the...
by Emily C | Mar 27, 2020 | Canadian Regulatory, Research/Science/Technology, U.S. Regulatory
During the current COVID-19 pandemic, the government’s regulatory bodies have decided to take supportive steps to discourage the spread of the virus. These steps include temporarily modifying the regulatory process for disinfectant and sanitization products to allow...
Recent Comments